Nevakar and zhaoke case study
Transaction Case Studies SUCCESSFUL CHINA SELL-SIDE LICENSING PROCESS FOR A TREATMENT FOR PEDIATRIC MYOPIA Situation Assessment Nevakar is a private […]
Uncategorized
Uncategorized
Twi
Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA
Locust Walk Webinar
Fundamentals and Recent Trends in Life Sciences Private Financing – March 15, 2018
Fundamentals and Recent Trends in Life Sciences Private Financing- webinar Fundamentals and Recent Trends in Life Sciences Private Financing- webinar
Locust Walk Webinar
BioPharma Partnering in Japan – December 18, 2017
Biopharma Partnering in Japan Biopharma Partnering in Japan This half an hour webinar will provide valuable education and insights into
Locust Walk Webinar
BioPharma Buy-Side Deal Process Keys to Success- June 13, 2017
BioPharma Buy-Side Deal Process Keys to Success BioPharma Buy-Side Deal Process Keys to Success The webinar will cover key issues
Locust Walk Webinar
Fundamentals and Key Trends in Life Sciences Private Financing- July 26, 2017
Fundamentals And Recent Trends in Life Sciences Private Financing Fundamentals And Recent Trends in Life Sciences Private Financing This one-hour,
Locust Walk Webinar
Biopharma Valuation Analysis
Webinar- Biopharma Valuation Analysis Biopharma Valuation Analysis The webinar will cover key issues surrounding how to best value a biopharma
News
Garuda Therapeutics Launches with $72 Million Series A Financing
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf,
News
Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing
News
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company